Autolus Therapeutics PLCNASDAQ:AUTL
- LAST PRICE4.2100
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots2.5000/ 1
- Ask / Lots4.5200/ 3
- Open / Previous Close0.0000 / 4.2100
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | AUTL |
|---|---|---|
| 09:32 ET | 5640 | 4.6 |
| 09:34 ET | 2800 | 4.5 |
| 09:36 ET | 3000 | 4.53 |
| 09:38 ET | 8561 | 4.48 |
| 09:39 ET | 1084 | 4.48 |
| 09:41 ET | 625 | 4.48 |
| 09:43 ET | 2000 | 4.495 |
| 09:45 ET | 3500 | 4.465 |
| 09:48 ET | 2361 | 4.445 |
| 09:50 ET | 1100 | 4.44 |
| 09:52 ET | 3548 | 4.455 |
| 09:54 ET | 625 | 4.46 |
| 09:56 ET | 2400 | 4.45 |
| 09:57 ET | 700 | 4.445 |
| 09:59 ET | 3868 | 4.39 |
| 10:01 ET | 9590 | 4.365 |
| 10:03 ET | 2556 | 4.37 |
| 10:06 ET | 10347 | 4.44 |
| 10:08 ET | 4953 | 4.48 |
| 10:10 ET | 8703 | 4.44 |
| 10:12 ET | 35812 | 4.44 |
| 10:14 ET | 144807 | 4.49 |
| 10:15 ET | 12252 | 4.47 |
| 10:17 ET | 21453 | 4.49 |
| 10:19 ET | 7176 | 4.47 |
| 10:21 ET | 31921 | 4.485 |
| 10:24 ET | 7113 | 4.46 |
| 10:26 ET | 1000 | 4.485 |
| 10:28 ET | 2093 | 4.48 |
| 10:30 ET | 2001 | 4.445 |
| 10:32 ET | 7005 | 4.445 |
| 10:33 ET | 5219 | 4.44 |
| 10:35 ET | 28814 | 4.44 |
| 10:37 ET | 2000 | 4.44 |
| 10:39 ET | 8581 | 4.44 |
| 10:42 ET | 13931 | 4.42 |
| 10:44 ET | 36646 | 4.4 |
| 10:46 ET | 1167 | 4.4 |
| 10:48 ET | 1000 | 4.4 |
| 10:50 ET | 300 | 4.4 |
| 10:51 ET | 104200 | 4.38 |
| 10:53 ET | 3998 | 4.3895 |
| 10:55 ET | 6904 | 4.38 |
| 10:57 ET | 400 | 4.37 |
| 11:00 ET | 3544 | 4.36 |
| 11:02 ET | 968 | 4.3598 |
| 11:04 ET | 1934 | 4.34 |
| 11:06 ET | 1246 | 4.34 |
| 11:08 ET | 12057 | 4.31 |
| 11:09 ET | 18553 | 4.3 |
| 11:11 ET | 8721 | 4.355 |
| 11:13 ET | 24146 | 4.39 |
| 11:15 ET | 18561 | 4.405 |
| 11:18 ET | 8135 | 4.395 |
| 11:20 ET | 3646 | 4.395 |
| 11:22 ET | 3100 | 4.365 |
| 11:24 ET | 100 | 4.375 |
| 11:26 ET | 2350 | 4.365 |
| 11:27 ET | 5155 | 4.4 |
| 11:29 ET | 2750 | 4.385 |
| 11:31 ET | 1883 | 4.4 |
| 11:33 ET | 200 | 4.405 |
| 11:36 ET | 6928 | 4.365 |
| 11:38 ET | 300 | 4.39 |
| 11:40 ET | 2805 | 4.39 |
| 11:42 ET | 329 | 4.375 |
| 11:44 ET | 200 | 4.38 |
| 11:45 ET | 2400 | 4.355 |
| 11:47 ET | 2300 | 4.36 |
| 11:49 ET | 1150 | 4.3414 |
| 11:51 ET | 9533 | 4.3401 |
| 11:54 ET | 2931 | 4.34 |
| 11:56 ET | 2471 | 4.34 |
| 11:58 ET | 5128 | 4.344 |
| 12:00 ET | 46801 | 4.33 |
| 12:02 ET | 1000 | 4.33 |
| 12:03 ET | 4454 | 4.3 |
| 12:05 ET | 45141 | 4.3 |
| 12:07 ET | 7317 | 4.285 |
| 12:09 ET | 1400 | 4.27 |
| 12:12 ET | 6946 | 4.29 |
| 12:14 ET | 1662 | 4.305 |
| 12:16 ET | 4200 | 4.3 |
| 12:18 ET | 430 | 4.295 |
| 12:20 ET | 5911 | 4.3 |
| 12:21 ET | 1864 | 4.295 |
| 12:23 ET | 100 | 4.3 |
| 12:25 ET | 48864 | 4.3 |
| 12:27 ET | 5186 | 4.29 |
| 12:30 ET | 8203 | 4.295 |
| 12:32 ET | 2042 | 4.29 |
| 12:34 ET | 3662 | 4.3 |
| 12:36 ET | 300 | 4.3 |
| 12:38 ET | 918 | 4.3 |
| 12:39 ET | 6552 | 4.3 |
| 12:41 ET | 4167 | 4.3 |
| 12:43 ET | 3160 | 4.291 |
| 12:45 ET | 1025 | 4.3 |
| 12:48 ET | 700 | 4.3 |
| 12:50 ET | 200 | 4.295 |
| 12:52 ET | 700 | 4.3 |
| 12:54 ET | 1650 | 4.295 |
| 12:56 ET | 300 | 4.295 |
| 12:57 ET | 35880 | 4.275 |
| 12:59 ET | 795 | 4.28 |
| 01:01 ET | 5573 | 4.28 |
| 01:03 ET | 500 | 4.28 |
| 01:06 ET | 3400 | 4.28 |
| 01:08 ET | 6945 | 4.265 |
| 01:10 ET | 400 | 4.265 |
| 01:12 ET | 652 | 4.27 |
| 01:14 ET | 163071 | 4.325 |
| 01:15 ET | 2941 | 4.315 |
| 01:17 ET | 11642 | 4.305 |
| 01:19 ET | 1563 | 4.3 |
| 01:21 ET | 1946 | 4.325 |
| 01:24 ET | 50458 | 4.33 |
| 01:26 ET | 42935 | 4.3 |
| 01:28 ET | 16007 | 4.305 |
| 01:30 ET | 336642 | 4.3225 |
| 01:32 ET | 25336 | 4.335 |
| 01:33 ET | 3816 | 4.335 |
| 01:35 ET | 5117 | 4.315 |
| 01:37 ET | 8620 | 4.295 |
| 01:39 ET | 2942 | 4.295 |
| 01:42 ET | 13359 | 4.285 |
| 01:44 ET | 5357 | 4.27 |
| 01:46 ET | 5934 | 4.275 |
| 01:48 ET | 8490 | 4.275 |
| 01:50 ET | 13946 | 4.29 |
| 01:51 ET | 6180 | 4.28 |
| 01:53 ET | 4411 | 4.28 |
| 01:55 ET | 19317 | 4.28 |
| 01:57 ET | 13928 | 4.29 |
| 02:00 ET | 5281 | 4.3 |
| 02:02 ET | 4997 | 4.3 |
| 02:04 ET | 19544 | 4.28 |
| 02:06 ET | 6422 | 4.265 |
| 02:08 ET | 11628 | 4.26 |
| 02:09 ET | 45105 | 4.25 |
| 02:11 ET | 3779 | 4.255 |
| 02:13 ET | 17886 | 4.26 |
| 02:15 ET | 1107 | 4.26 |
| 02:18 ET | 9716 | 4.26 |
| 02:20 ET | 20937 | 4.275 |
| 02:22 ET | 1300 | 4.28 |
| 02:24 ET | 2827 | 4.275 |
| 02:26 ET | 300 | 4.275 |
| 02:27 ET | 200 | 4.275 |
| 02:29 ET | 6931 | 4.265 |
| 02:31 ET | 6459 | 4.2599 |
| 02:33 ET | 1600 | 4.26 |
| 02:36 ET | 633 | 4.25 |
| 02:38 ET | 1861 | 4.265 |
| 02:40 ET | 12950 | 4.265 |
| 02:42 ET | 700 | 4.265 |
| 02:44 ET | 300 | 4.265 |
| 02:45 ET | 400 | 4.265 |
| 02:47 ET | 938 | 4.265 |
| 02:49 ET | 700 | 4.265 |
| 02:51 ET | 5383 | 4.255 |
| 02:54 ET | 7675 | 4.2399 |
| 02:56 ET | 1604 | 4.25 |
| 02:58 ET | 5690 | 4.2492 |
| 03:00 ET | 200 | 4.245 |
| 03:02 ET | 12175 | 4.225 |
| 03:03 ET | 200 | 4.225 |
| 03:05 ET | 4549 | 4.215 |
| 03:07 ET | 17406 | 4.2 |
| 03:09 ET | 2800 | 4.19 |
| 03:12 ET | 7525 | 4.18 |
| 03:14 ET | 54797 | 4.195 |
| 03:16 ET | 864 | 4.195 |
| 03:18 ET | 11195 | 4.195 |
| 03:20 ET | 8770 | 4.18 |
| 03:21 ET | 56411 | 4.175 |
| 03:23 ET | 8307 | 4.195 |
| 03:25 ET | 928 | 4.21 |
| 03:27 ET | 1691 | 4.195 |
| 03:30 ET | 11338 | 4.215 |
| 03:32 ET | 3628 | 4.22 |
| 03:34 ET | 6216 | 4.24 |
| 03:36 ET | 3622 | 4.25 |
| 03:38 ET | 2768 | 4.24 |
| 03:39 ET | 3975 | 4.235 |
| 03:41 ET | 6238 | 4.26 |
| 03:43 ET | 10749 | 4.24 |
| 03:45 ET | 12115 | 4.245 |
| 03:48 ET | 7028 | 4.245 |
| 03:50 ET | 22989 | 4.25 |
| 03:52 ET | 55976 | 4.205 |
| 03:54 ET | 28580 | 4.215 |
| 03:56 ET | 42692 | 4.22 |
| 03:57 ET | 26092 | 4.235 |
| 03:59 ET | 67696 | 4.21 |
Yesterday
Apr 23, 2024
Autolus Therapeutics to Report First Quarter 2024 Financial Results and Host Conference Call on May 14, 2024, from 7:00AM ET on Tuesday Apr 23, 2024 by Dow Jones
7:00AM ET on Tuesday Apr 23, 2024 by Dow Jones
Apr 12, 2024
DJ Autolus Therapeutics Price Target Maintained With a $9.00/Share by Needham, from 6:12AM ET on Friday Apr 12, 2024 by Dow Jones
6:12AM ET on Friday Apr 12, 2024 by Dow Jones
Apr 9, 2024
DJ Autolus Therapeutics Is Maintained at Buy by Truist Securities, from 1:51PM ET on Tuesday Apr 09, 2024 by Dow Jones
1:51PM ET on Tuesday Apr 09, 2024 by Dow Jones
Apr 2, 2024
Autolus Therapeutics announces acceptance of Marketing Authorization Application (MAA) by the European Medicines Agency (EMA) for obecabtagene autoleucel (obe-cel) for Patients with Relapsed/refractory (r/r) Adult B-Cell Acute Lymphoblastic Leukemia (B-ALL), from 7:00AM ET on Tuesday Apr 02, 2024 by Dow Jones
7:00AM ET on Tuesday Apr 02, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Autolus Therapeutics PLC | 1.1B | -3.5x | --- |
Belite Bio Inc | 1.1B | -30.0x | --- |
Scholar Rock Holding Corp | 1.1B | -7.1x | --- |
Spyre Therapeutics Inc | 1.2B | -0.4x | --- |
Pharvaris NV | 1.1B | -7.9x | --- |
Verona Pharma PLC | 1.2B | -22.2x | --- |
Company Information
Autolus Therapeutics plc is a United Kingdom-based clinical-stage biopharmaceutical company developing programmed T cell therapies for the treatment of cancer and autoimmune diseases. It is focused on chimeric antigen receptor (CAR)-T cell therapy. Using a suite of proprietary and modular T cell programming technologies, it is engineering targeted, controlled and highly active T cell therapy product candidates that are designed to recognize target cells, break down their defense mechanisms and eliminate these cells. It has a pipeline of product candidates in development for the treatment of hematological malignancies, solid tumors and autoimmune diseases. Its products pipeline includes obe-cel (FELIX), obe-cel (ALLCAR19), obe-cel (CAROUSEL), AUTO1/22 (CARPALL), AUTO4 (LibrA T1), AUTO6 (MAGNETO), AUTO5, AUTO8 (MCARTY) and AUTO9. AUTO4 and AUTO5 are two programmed T cell therapies for the treatment of peripheral T-cell lymphoma targeting T Cell Receptor Beta Constant (TRBC) 1 and TRBC 2.
Contact Information
- Headquarters
- The Mediaworks, 191 Wood LaneLONDON, United Kingdom W12 7FP
- Phone
- 203-829-6230
- Fax
- ---
Executives
- Chairman of the Board
- Michael Bonney
- Chief Executive Officer, Executive Director
- Christian Itin
- Founder, Senior Vice President, Chief Scientific Officer
- Martin Pule
- Chief Financial Officer, Senior Vice President
- Lucinda Crabtree
- Chief Operating Officer, Senior Vice President
- Christopher Vann
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $1.1B |
|---|---|
Revenue (TTM) | $1.7M |
Shares Outstanding | 265.9M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 2.00 |
EPS | $-1.20 |
Book Value | --- |
P/E Ratio | -3.5x |
Price/Sales (TTM) | 659.3 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -10,583.10% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
